Enrofloxacin CAS No. 93106-60-6 (GMP/COPP/WC/ISO/DMF) Veterinary Antibacterial API
02
introduce
Enrofloxacin is exclusive veterinary fluoroquinolone raw material with broad-spectrum bactericidal activity against Gram-positive, Gram-negative bacteria and mycoplasma. It features excellent tissue distribution and is widely applied in livestock, poultry and aquaculture disease treatment.
Our strict quality control ensures consistent batch performance for pharmaceutical production needs.
Our strict quality control ensures consistent batch performance for pharmaceutical production needs.
02
Physical and chemical properties
Enrofloxacin i possesses key physical and chemical characteristics as follows:
- Density: 1.385±0.06 g/cm³
- Melting Point: 221–226 °C
- Boiling Point: 560.5±50.0 °C
- Storage Condition: Sealed dry environment at 2–8 °C, avoid light
- Solubility: Slightly soluble in water, chloroform and heated methanol; soluble in dilute acid/alkaline solution
- Hygroscopicity: Slightly hygroscopic, easy to discolor under long-term light exposure
- Density: 1.385±0.06 g/cm³
- Melting Point: 221–226 °C
- Boiling Point: 560.5±50.0 °C
- Storage Condition: Sealed dry environment at 2–8 °C, avoid light
- Solubility: Slightly soluble in water, chloroform and heated methanol; soluble in dilute acid/alkaline solution
- Hygroscopicity: Slightly hygroscopic, easy to discolor under long-term light exposure
Ultra-wide Antibacterial Spectrum
Effective against E. coli, Salmonella, Pasteurella, Staphylococcus and various mycoplasma, superior activity than norfloxacin against mycoplasma.
Effective against E. coli, Salmonella, Pasteurella, Staphylococcus and various mycoplasma, superior activity than norfloxacin against mycoplasma.
Excellent Tissue Penetration
Rapid absorption via oral, intramuscular or subcutaneous routes; drug concentration in most tissues exceeds blood level except central nervous system.
Active Metabolite Conversion
Degrades into ciprofloxacin in vivo, delivering dual antibacterial effects to enhance therapeutic outcome.
Flexible Formulation Adaptability
Suitable for injection, oral solution, premix and soluble powder production.
Low Toxicity Profile
Low acute toxicity; no teratogenic or mutagenic risk at therapeutic doses, with clear animal withdrawal standards.
Synergistic Compatibility
Shows synergistic antibacterial effect when combined with aminoglycosides and polymyxins under separate administration.
Livestock & Poultry Veterinary
Treat respiratory, digestive, urinary tract, skin mixed bacterial and mycoplasma infections in pigs, cattle, chickens and turkeys; control septicemia and secondary viral bacterial complications.
Treat respiratory, digestive, urinary tract, skin mixed bacterial and mycoplasma infections in pigs, cattle, chickens and turkeys; control septicemia and secondary viral bacterial complications.
Companion Animal Medicine
Core raw material for dog and cat formulations for otitis externa, urinary tract infection, wound infection and respiratory disease.
Aquaculture
Used for bacterial disease prevention and treatment in fish, shrimp and other aquatic species via feed mixing or water administration.
Laboratory Research
Standard antibacterial reference substance for microbial susceptibility testing and fluoroquinolone pharmacology research.
Enrofloxacin is a mature exclusive veterinary fluoroquinolone API with broad bactericidal range, high tissue permeability and diversified formulation compatibility. It remains the mainstream raw material for animal bacterial and mycoplasma infection treatment, maintaining stable market demand across livestock, pet and aquaculture industries.
Contact our team today for sample requests, technical specifications and bulk order inquiries—we’re committed to providing efficient and customized veterinary raw material solutions for you.
Contact our team today for sample requests, technical specifications and bulk order inquiries—we’re committed to providing efficient and customized veterinary raw material solutions for you.